FPR1 Antagonist (BOC-MLF) Inhibits Amniotic Epithelial-mesenchymal Transition

ConclusionThe expression of FPR1 in the fetal membrane of PROM was significantly increased, and EMT of the amniotic membrane was obvious. BOC-MLF can treat inflammation and inhibit amniotic EMT.

Source: Journal of Huazhong University of Science and Technology -- Medical Sciences -- - February 1, 2024 Category: Research Source Type: research